Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
A better-than-expected first quarter and a goal of profitability and positive cash flow by the end of 2025 brought on a bit of a rally.
BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024
Stocks that traded heavily or had substantial price changes on Monday: BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
BCRX earnings call for the period ending March 31, 2024.
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
BCRX earnings call for the period ending December 31, 2023.
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
BCRX earnings call for the period ending September 30, 2023.
3 Magnificent Growth Stocks to Buy on the Dip
These three biotech stocks are attractive buys right now.
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript
BCRX earnings call for the period ending June 30, 2023.